OMX Copenhagen 20
2.095,60
PKT
+75,49
PKT
+3,74
%
Werbung
Analysen zu OMX Copenhagen 20-Werten
Datum | Rating | Analyst | |
---|---|---|---|
17.01.18 | Novo Nordisk buy | Deutsche Bank AG | |
16.01.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
16.01.18 | Novo Nordisk market-perform | Bernstein Research | |
15.01.18 | Novo Nordisk buy | UBS AG | |
12.01.18 | Novo Nordisk buy | UBS AG | |
09.01.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
09.01.18 | Novo Nordisk buy | Deutsche Bank AG | |
08.01.18 | Novo Nordisk buy | UBS AG | |
29.12.17 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
15.12.17 | Novo Nordisk Verkaufen | DZ BANK | |
12.12.17 | Novo Nordisk buy | UBS AG | |
07.12.17 | Novo Nordisk Reduce | HSBC | |
06.12.17 | Novo Nordisk overweight | Morgan Stanley | |
06.12.17 | Novo Nordisk buy | UBS AG | |
06.12.17 | Novo Nordisk buy | Deutsche Bank AG | |
06.12.17 | Novo Nordisk buy | Merrill Lynch & Co., Inc. | |
06.12.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
06.12.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
01.12.17 | Novo Nordisk overweight | Morgan Stanley | |
28.11.17 | Novo Nordisk buy | UBS AG | |
22.11.17 | Novo Nordisk Equal-Weight | Morgan Stanley | |
22.11.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
22.11.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
16.11.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
15.11.17 | Novo Nordisk Underweight | Barclays Capital | |
03.11.17 | Novo Nordisk Hold | S&P Capital IQ | |
02.11.17 | Novo Nordisk buy | Deutsche Bank AG | |
02.11.17 | Novo Nordisk Equal-Weight | Morgan Stanley | |
02.11.17 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
02.11.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
02.11.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
01.11.17 | Novo Nordisk buy | UBS AG | |
27.10.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
26.10.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
23.10.17 | Novo Nordisk buy | UBS AG | |
20.10.17 | Novo Nordisk Equal-Weight | Morgan Stanley | |
19.10.17 | Novo Nordisk Neutral | Citigroup Corp. | |
19.10.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
17.10.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
17.10.17 | Novo Nordisk buy | UBS AG |